SINGAPORE, March 30, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Development and Manufacturing Organization Award" on the Asia ...
CAR-T-cell therapies are revolutionizing the treatment of blood cancers, and their full potential is still being explored in hundreds of clinical trials. In this therapy, a patient’s own T cells are ...
New therapeutic possibilities for various diseases are made possible via mRNA. The adaptability of in vitro transcribed (IVT) mRNA is largely due to its simpler cell-free manufacture, cell ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Gene synthesis is a ...
What is collectively needed, both companies maintain, are more efficient, safer, and scalable approaches to cell engineering.
GenScript Biotech Holdings surged in Hong Kong after its associate company disclosed promising early clinical data on a potential first-in-class cell therapy for treating cancer. Shares rose as much ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
In 1998, Isabelle Rivière was recruited to lead a new cell and gene therapy facility at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York. MSKCC was pioneering cell therapy for blood ...
Stay informed on the latest manufacturing industry news. Read press releases covering aerospace, automotive, engineering, machinery, packaging, and textiles. Discover trends, innovations, and key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results